# Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

> **NCT02550717** · — · COMPLETED · sponsor: **Bayer** · enrollment: 398158 (actual)

## Conditions studied

- Secondary Prevention
- Stroke
- Ischemic Heart Disease
- Coronary Heart Disease

## Interventions

- **DRUG:** Acetylsalicylic Acid (Aspirin, BAYE4465)
- **DRUG:** Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs

## Key facts

- **NCT ID:** NCT02550717
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 398158 (ACTUAL)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550717, "Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02550717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*